Enhanced Group Inc. started trading on the NYSE in early May following its combination with Paradise Acquisition Corp. The telehealth firm focuses on peptides and performance-enhancing products.
The company offers peptides and supplemental health products aimed at the biohacking market. It went public through the SPAC deal that created a new listed telehealth stock.
由 AI 报道 AI 生成的图像
Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.
SpaceX made its historic NASDAQ debut on Friday with shares closing 19% higher. The company's valuation surged past $2 trillion, making it the sixth-largest U.S. firm by market value. The IPO raised $75 billion despite a reported loss last year.
由 AI 报道
GoodRx received an upgrade to a neutral rating following its first-quarter earnings report.
Executives from Alliance Entertainment Holding Corporation outlined the company's transformation into a leading omnichannel platform for physical media and collectibles during a presentation on April 7. The NASDAQ-listed firm highlighted its extensive inventory and distribution capabilities. Bruce Ogilvie, the executive chairman, described the company as a powerhouse in the collectibles culture.
由 AI 报道
Several Johannesburg Stock Exchange listed firms have posted encouraging results ahead of the reporting season. Tech companies Altron, Datatec and Lesaka, hotel group Southern Sun and brewer AB InBev all delivered positive trading updates for periods ending in February or March 2026.
Mobility Global welcomed investors to its first investor day on May 12. The event focused on the company's planned separation from S&P Global to become an independent public company in mid-2026.
由 AI 报道
Palantir Technologies Inc. delivered exceptional first-quarter results, with revenue exceeding consensus estimates by 6% and earnings per share nearly 20% above forecasts. The company's revenue grew over 80% year-over-year, outpacing most tech peers. Despite the strong performance, shares did not rally amid valuation concerns.